Click here to get full coverage on Castle Biosciences' TissueCypher® Test Surpasses 100,000 Orders, Advancing Precision Risk Assessment for Patients with Barrett's Esophagus - PR Newswire

Castle Biosciences' TissueCypher® Test Surpasses 100,000 Orders, Advancing Precision Risk Assessment for Patients with Barrett's Esophagus  PR Newswire

Castle Biosciences' TissueCypher® Test Surpasses 100,000 Orders, Advancing Precision Risk Assessment for Patients with Barrett's Esophagus - PR Newswire

Click here to get full coverage on Castle Biosciences (CSTL) COO sells 8,587 shares, retains over 127K - Stock Titan

Castle Biosciences (CSTL) COO sells 8,587 shares, retains over 127K  Stock Titan

Castle Biosciences (CSTL) COO sells 8,587 shares, retains over 127K - Stock Titan

Click here to get full coverage on How The Castle Biosciences (CSTL) Investment Story Is Evolving Without Fresh Analyst Commentary - Yahoo Finance

How The Castle Biosciences (CSTL) Investment Story Is Evolving Without Fresh Analyst Commentary  Yahoo Finance

How The Castle Biosciences (CSTL) Investment Story Is Evolving Without Fresh Analyst Commentary - Yahoo Finance

Click here to get full coverage on Castle Biosciences (CSTL) Surpasses 100,000 TissueCypher Test Or - GuruFocus

Castle Biosciences (CSTL) Surpasses 100,000 TissueCypher Test Or  GuruFocus

Castle Biosciences (CSTL) Surpasses 100,000 TissueCypher Test Or - GuruFocus

Click here to get full coverage on Castle Biosciences Inc (CSTL) Institutional Confidence - TradingKey

Castle Biosciences Inc (CSTL) Institutional Confidence  TradingKey

Castle Biosciences Inc (CSTL) Institutional Confidence - TradingKey

Click here to get full coverage on CSTL: Raised 2026 revenue guidance on strong test growth and innovation in dermatology and GI - TradingView

CSTL: Raised 2026 revenue guidance on strong test growth and innovation in dermatology and GI  TradingView

CSTL: Raised 2026 revenue guidance on strong test growth and innovation in dermatology and GI - TradingView

Click here to get full coverage on Trading the Move, Not the Narrative: (CSTL) Edition - Stock Traders Daily

Trading the Move, Not the Narrative: (CSTL) Edition  Stock Traders Daily

Trading the Move, Not the Narrative: (CSTL) Edition - Stock Traders Daily

Click here to get full coverage on New Analyst Forecast: $CSTL Given $40 Price Target - Quiver Quantitative

New Analyst Forecast: $CSTL Given $40 Price Target  Quiver Quantitative

New Analyst Forecast: $CSTL Given $40 Price Target - Quiver Quantitative

Click here to get full coverage on Castle Biosciences (CSTL) CEO Maetzold exercises options, trusts sell 4,172 shares - Stock Titan

Castle Biosciences (CSTL) CEO Maetzold exercises options, trusts sell 4,172 shares  Stock Titan

Castle Biosciences (CSTL) CEO Maetzold exercises options, trusts sell 4,172 shares - Stock Titan

Click here to get full coverage on How The Castle Biosciences (CSTL) Story Is Shifting After Solid Q1 And Lower Targets - Yahoo Finance

How The Castle Biosciences (CSTL) Story Is Shifting After Solid Q1 And Lower Targets  Yahoo Finance

How The Castle Biosciences (CSTL) Story Is Shifting After Solid Q1 And Lower Targets - Yahoo Finance

Click here to get full coverage on Castle Biosciences Inc (CSTL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Castle Biosciences Inc (CSTL) Financial Health: Profitability & Balance Sheet Analysis  TradingKey

Castle Biosciences Inc (CSTL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Click here to get full coverage on CSTL: Raised 2026 guidance after strong Q1 growth and expanded diagnostic test adoption - TradingView

CSTL: Raised 2026 guidance after strong Q1 growth and expanded diagnostic test adoption  TradingView

CSTL: Raised 2026 guidance after strong Q1 growth and expanded diagnostic test adoption - TradingView

Click here to get full coverage on Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  PR Newswire

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire

Click here to get full coverage on CSTL (NASDAQ) Rule 144 notice: director sale notice for 4,152 shares - Stock Titan

CSTL (NASDAQ) Rule 144 notice: director sale notice for 4,152 shares  Stock Titan

CSTL (NASDAQ) Rule 144 notice: director sale notice for 4,152 shares - Stock Titan

Click here to get full coverage on Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance

Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue Estimates  Yahoo Finance

Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance

Click here to get full coverage on Castle Biosciences Inc (CSTL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Castle Biosciences Inc (CSTL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution  TradingKey

Castle Biosciences Inc (CSTL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Click here to get full coverage on Why The Narrative Around Castle Biosciences (CSTL) Is Shifting With New Revenue Targets - Yahoo Finance

Why The Narrative Around Castle Biosciences (CSTL) Is Shifting With New Revenue Targets  Yahoo Finance

Why The Narrative Around Castle Biosciences (CSTL) Is Shifting With New Revenue Targets - Yahoo Finance

Click here to get full coverage on Castle Biosciences Inc (CSTL) Valuation: PE, PB & Fair Value Analysis - TradingKey

Castle Biosciences Inc (CSTL) Valuation: PE, PB & Fair Value Analysis  TradingKey

Castle Biosciences Inc (CSTL) Valuation: PE, PB & Fair Value Analysis - TradingKey

Click here to get full coverage on Maetzold-related trusts sell shares (CSTL) in multiple Form 144 trades - Stock Titan

Maetzold-related trusts sell shares (CSTL) in multiple Form 144 trades  Stock Titan

Maetzold-related trusts sell shares (CSTL) in multiple Form 144 trades - Stock Titan

Click here to get full coverage on Castle Biosciences Inc (CSTL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Castle Biosciences Inc (CSTL) Risk Assessment: Volatility, Financial Risk & Investment Risk  TradingKey

Castle Biosciences Inc (CSTL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Click here to get full coverage on Director at Castle Biosciences (CSTL) receives 11,766 RSU equity award - Stock Titan

Director at Castle Biosciences (CSTL) receives 11,766 RSU equity award  Stock Titan

Director at Castle Biosciences (CSTL) receives 11,766 RSU equity award - Stock Titan

Click here to get full coverage on (CSTL) Volatility Zones as Tactical Triggers - Stock Traders Daily

(CSTL) Volatility Zones as Tactical Triggers  Stock Traders Daily

(CSTL) Volatility Zones as Tactical Triggers - Stock Traders Daily

Click here to get full coverage on Castle Biosciences (CSTL) Q1 Loss Of US$14.5 Million Tests Profitability Narrative - simplywall.st

Castle Biosciences (CSTL) Q1 Loss Of US$14.5 Million Tests Profitability Narrative  simplywall.st

Castle Biosciences (CSTL) Q1 Loss Of US$14.5 Million Tests Profitability Narrative - simplywall.st

Click here to get full coverage on Stokes Frank sells Castle Biosciences (CSTL) stock worth $192k - Investing.com

Stokes Frank sells Castle Biosciences (CSTL) stock worth $192k  Investing.com

Stokes Frank sells Castle Biosciences (CSTL) stock worth $192k - Investing.com

Click here to get full coverage on Castle Biosciences: Buying The Remaining DecisionDx-Melanoma Upside (NASDAQ:CSTL) - Seeking Alpha

Castle Biosciences: Buying The Remaining DecisionDx-Melanoma Upside (NASDAQ:CSTL)  Seeking Alpha

Castle Biosciences: Buying The Remaining DecisionDx-Melanoma Upside (NASDAQ:CSTL) - Seeking Alpha

Click here to get full coverage on Castle Biosciences (CSTL) director converts 13,667 RSUs into Common Stock - Stock Titan

Castle Biosciences (CSTL) director converts 13,667 RSUs into Common Stock  Stock Titan

Castle Biosciences (CSTL) director converts 13,667 RSUs into Common Stock - Stock Titan

Click here to get full coverage on Castle Biosciences, Inc.'s (NASDAQ:CSTL) 44% Share Price Surge Not Quite Adding Up - simplywall.st

Castle Biosciences, Inc.'s (NASDAQ:CSTL) 44% Share Price Surge Not Quite Adding Up  simplywall.st

Castle Biosciences, Inc.'s (NASDAQ:CSTL) 44% Share Price Surge Not Quite Adding Up - simplywall.st

Click here to get full coverage on Castle Biosciences president & CEO Derek J. Maetzold sells $86,193 stock - Investing.com

Castle Biosciences president & CEO Derek J. Maetzold sells $86,193 stock  Investing.com

Castle Biosciences president & CEO Derek J. Maetzold sells $86,193 stock - Investing.com

Click here to get full coverage on Are You Looking for a Top Momentum Pick? Why Castle Biosciences, Inc. (CSTL) is a Great Choice - Yahoo Finance

Are You Looking for a Top Momentum Pick? Why Castle Biosciences, Inc. (CSTL) is a Great Choice  Yahoo Finance

Are You Looking for a Top Momentum Pick? Why Castle Biosciences, Inc. (CSTL) is a Great Choice - Yahoo Finance

Click here to get full coverage on Maetzold, Castle Biosciences CEO, sells $500k in CSTL stock - Investing.com

Maetzold, Castle Biosciences CEO, sells $500k in CSTL stock  Investing.com

Maetzold, Castle Biosciences CEO, sells $500k in CSTL stock - Investing.com

Click here to get full coverage on Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference - PR Newswire

Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference  PR Newswire

Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference - PR Newswire

Click here to get full coverage on How Investors Are Reacting To Castle Biosciences (CSTL) Upgraded 2025 Revenue Outlook And Test Volume Growth - simplywall.st

How Investors Are Reacting To Castle Biosciences (CSTL) Upgraded 2025 Revenue Outlook And Test Volume Growth  simplywall.st

How Investors Are Reacting To Castle Biosciences (CSTL) Upgraded 2025 Revenue Outlook And Test Volume Growth - simplywall.st

Click here to get full coverage on Castle Biosciences Reports 37% Increase in Core Test Reports for 2025, Achieving $344 Million in Revenue - Quiver Quantitative

Castle Biosciences Reports 37% Increase in Core Test Reports for 2025, Achieving $344 Million in Revenue  Quiver Quantitative

Castle Biosciences Reports 37% Increase in Core Test Reports for 2025, Achieving $344 Million in Revenue - Quiver Quantitative

Click here to get full coverage on Free skin cancer screenings roll out nationwide with Castle support - Stock Titan

Free skin cancer screenings roll out nationwide with Castle support  Stock Titan

Free skin cancer screenings roll out nationwide with Castle support - Stock Titan

Click here to get full coverage on Castle Biosciences, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

Castle Biosciences, Inc. Q1 2026 Earnings Call Summary  Yahoo Finance

Castle Biosciences, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

Click here to get full coverage on Castle Biosciences (CSTL) Study Validates DecisionDx-Melanoma Te - GuruFocus

Castle Biosciences (CSTL) Study Validates DecisionDx-Melanoma Te  GuruFocus

Castle Biosciences (CSTL) Study Validates DecisionDx-Melanoma Te - GuruFocus

Click here to get full coverage on Viatris Stock to Report Q4 Earnings: What's in the Cards? - TradingView

Viatris Stock to Report Q4 Earnings: What's in the Cards?  TradingView

Viatris Stock to Report Q4 Earnings: What's in the Cards? - TradingView

Click here to get full coverage on Castle Biosciences Q1 2026 slides: revenue beats, guidance raised - Investing.com

Castle Biosciences Q1 2026 slides: revenue beats, guidance raised  Investing.com

Castle Biosciences Q1 2026 slides: revenue beats, guidance raised - Investing.com

Click here to get full coverage on Castle Biosciences beats Q1 revenue estimates, raises FY revenue outlook - TradingView

Castle Biosciences beats Q1 revenue estimates, raises FY revenue outlook  TradingView

Castle Biosciences beats Q1 revenue estimates, raises FY revenue outlook - TradingView

Click here to get full coverage on Castle Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary - TradingView

Castle Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary  TradingView

Castle Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary - TradingView

Click here to get full coverage on Castle Biosciences Named to Newsweek's Inaugural America's Greatest Companies List for 2025 - Quiver Quantitative

Castle Biosciences Named to Newsweek's Inaugural America's Greatest Companies List for 2025  Quiver Quantitative

Castle Biosciences Named to Newsweek's Inaugural America's Greatest Companies List for 2025 - Quiver Quantitative

Click here to get full coverage on Castle Biosciences' TissueCypher® Test Provides New Insights for Barrett’s Esophagus Management at ACG 2025 Annual Meeting - Quiver Quantitative

Castle Biosciences' TissueCypher® Test Provides New Insights for Barrett’s Esophagus Management at ACG 2025 Annual Meeting  Quiver Quantitative

Castle Biosciences' TissueCypher® Test Provides New Insights for Barrett’s Esophagus Management at ACG 2025 Annual Meeting - Quiver Quantitative

Click here to get full coverage on Castle Biosciences to Release First Quarter 2026 Financial Results and Host Webcast on Wednesday, May 6, 2026 - Yahoo Finance

Castle Biosciences to Release First Quarter 2026 Financial Results and Host Webcast on Wednesday, May 6, 2026  Yahoo Finance

Castle Biosciences to Release First Quarter 2026 Financial Results and Host Webcast on Wednesday, May 6, 2026 - Yahoo Finance

Click here to get full coverage on Castle Biosciences stock hits 52-week high at $42.25 - Investing.com

Castle Biosciences stock hits 52-week high at $42.25  Investing.com

Castle Biosciences stock hits 52-week high at $42.25 - Investing.com

Click here to get full coverage on These stocks are moving in today's pre-market session - ChartMill

These stocks are moving in today's pre-market session  ChartMill

These stocks are moving in today's pre-market session - ChartMill

Click here to get full coverage on Zoetis Gears Up to Report Q4 Earnings: Here's What to Expect - Finviz

Zoetis Gears Up to Report Q4 Earnings: Here's What to Expect  Finviz

Zoetis Gears Up to Report Q4 Earnings: Here's What to Expect - Finviz

Click here to get full coverage on Castle Biosciences Earns 2026 USA TODAY Top Workplaces Award for Fifth Consecutive Year - PR Newswire

Castle Biosciences Earns 2026 USA TODAY Top Workplaces Award for Fifth Consecutive Year  PR Newswire

Castle Biosciences Earns 2026 USA TODAY Top Workplaces Award for Fifth Consecutive Year - PR Newswire

Click here to get full coverage on Castle Biosciences, Inc. to Release Second Quarter Financial Results on August 4, 2025 - Quiver Quantitative

Castle Biosciences, Inc. to Release Second Quarter Financial Results on August 4, 2025  Quiver Quantitative

Castle Biosciences, Inc. to Release Second Quarter Financial Results on August 4, 2025 - Quiver Quantitative

Click here to get full coverage on Viking Therapeutics to Report Q4 Earnings: Here's What to Know - Finviz

Viking Therapeutics to Report Q4 Earnings: Here's What to Know  Finviz

Viking Therapeutics to Report Q4 Earnings: Here's What to Know - Finviz

Click here to get full coverage on Castle Biosciences stock (US14843C1053): shares steady after recent Q1 2024 update - AD HOC NEWS

Castle Biosciences stock (US14843C1053): shares steady after recent Q1 2024 update  AD HOC NEWS

Castle Biosciences stock (US14843C1053): shares steady after recent Q1 2024 update - AD HOC NEWS

Click here to get full coverage on Clean Science & Technology Grants 5,000 Employee Stock Options at Rs.500 Exercise Price Under ESOP Scheme 2021 - scanx.trade

Clean Science & Technology Grants 5,000 Employee Stock Options at Rs.500 Exercise Price Under ESOP Scheme 2021  scanx.trade

Clean Science & Technology Grants 5,000 Employee Stock Options at Rs.500 Exercise Price Under ESOP Scheme 2021 - scanx.trade

Click here to get full coverage on Castle Biosciences (CSTL) Champions Skin Cancer Awareness Initia - GuruFocus

Castle Biosciences (CSTL) Champions Skin Cancer Awareness Initia  GuruFocus

Castle Biosciences (CSTL) Champions Skin Cancer Awareness Initia - GuruFocus

Click here to get full coverage on CSTL Expands its Dinosaur Exhibit Adding Life-Like Animatronic Models and More - Mommy Poppins

CSTL Expands its Dinosaur Exhibit Adding Life-Like Animatronic Models and More  Mommy Poppins

CSTL Expands its Dinosaur Exhibit Adding Life-Like Animatronic Models and More - Mommy Poppins

Click here to get full coverage on Castle Biosciences Stock Price Forecast. Should You Buy CSTL? - StockInvest.us

Castle Biosciences Stock Price Forecast. Should You Buy CSTL?  StockInvest.us

Castle Biosciences Stock Price Forecast. Should You Buy CSTL? - StockInvest.us

Click here to get full coverage on Castle Biosciences to Acquire Previse - GlobeNewswire

Castle Biosciences to Acquire Previse  GlobeNewswire

Castle Biosciences to Acquire Previse - GlobeNewswire

Click here to get full coverage on Castle Biosciences Announces Definitive Agreement to Acquire Previse, Enhancing Gastroenterology Offerings - Quiver Quantitative

Castle Biosciences Announces Definitive Agreement to Acquire Previse, Enhancing Gastroenterology Offerings  Quiver Quantitative

Castle Biosciences Announces Definitive Agreement to Acquire Previse, Enhancing Gastroenterology Offerings - Quiver Quantitative

Click here to get full coverage on WE CAME, WE SAW, WE SENT IT | DIYX CSTL JAM - Monster Energy

WE CAME, WE SAW, WE SENT IT | DIYX CSTL JAM  Monster Energy

WE CAME, WE SAW, WE SENT IT | DIYX CSTL JAM - Monster Energy

Click here to get full coverage on The Fittest on Earth - CrossFit Games

The Fittest on Earth - CrossFit Games

Click here to get full coverage on Technical Analysis of Castle Biosciences, Inc. (NASDAQ:CSTL) - TradingView

Technical Analysis of Castle Biosciences, Inc. (NASDAQ:CSTL)  TradingView

Technical Analysis of Castle Biosciences, Inc. (NASDAQ:CSTL) - TradingView

Click here to get full coverage on Rockville Centre’s dinosaur exhibit adds two attractions - Greater Long Island

Rockville Centre’s dinosaur exhibit adds two attractions  Greater Long Island

Rockville Centre’s dinosaur exhibit adds two attractions - Greater Long Island

Click here to get full coverage on Castle Biosciences Inc. (CSTL) Share Price Today | Castle Biosciences (CSTL) Live NSE/BSE - Value Research

Castle Biosciences Inc. (CSTL) Share Price Today | Castle Biosciences (CSTL) Live NSE/BSE  Value Research

Castle Biosciences Inc. (CSTL) Share Price Today | Castle Biosciences (CSTL) Live NSE/BSE - Value Research

Click here to get full coverage on Top Castle Biosciences (CSTL) Competitors 2026 - MarketBeat

Top Castle Biosciences (CSTL) Competitors 2026  MarketBeat

Top Castle Biosciences (CSTL) Competitors 2026 - MarketBeat

Click here to get full coverage on Representing Hong Kong: CrossFit CSTL - CrossFit Games

Representing Hong Kong: CrossFit CSTL  CrossFit Games

Representing Hong Kong: CrossFit CSTL - CrossFit Games

Click here to get full coverage on CASTLE ALERT: Bragar Eagel & Squire, P.C. is Investigating Castle Biosciences, Inc. on Behalf of Castle Stockholders and Encourages Investors to Contact the Firm - Business Wire

CASTLE ALERT: Bragar Eagel & Squire, P.C. is Investigating Castle Biosciences, Inc. on Behalf of Castle Stockholders and Encourages Investors to Contact the Firm  Business Wire

CASTLE ALERT: Bragar Eagel & Squire, P.C. is Investigating Castle Biosciences, Inc. on Behalf of Castle Stockholders and Encourages Investors to Contact the Firm - Business Wire

Click here to get full coverage on Castle Biosciences (CSTL) Earnings Date and Reports 2026 $CSTL - MarketBeat

Castle Biosciences (CSTL) Earnings Date and Reports 2026 $CSTL  MarketBeat

Castle Biosciences (CSTL) Earnings Date and Reports 2026 $CSTL - MarketBeat

Click here to get full coverage on Castle Biosciences (CSTL) Insider Trading Activity 2026 $CSTL - MarketBeat

Castle Biosciences (CSTL) Insider Trading Activity 2026 $CSTL  MarketBeat

Castle Biosciences (CSTL) Insider Trading Activity 2026 $CSTL - MarketBeat

Click here to get full coverage on TWC, PAL, CSTL Bring STEM To Maple Academy - qgazette.com

TWC, PAL, CSTL Bring STEM To Maple Academy  qgazette.com

TWC, PAL, CSTL Bring STEM To Maple Academy - qgazette.com

Click here to get full coverage on Camping-themed restaurant ESCAPE at Venture Drive has S$1.50 skewers & karaoke - Confirm Good

Camping-themed restaurant ESCAPE at Venture Drive has S$1.50 skewers & karaoke  Confirm Good

CSTL

Price Chart

Key Statistics

Technicals

About CSTL

Latest News

Castle Biosciences' TissueCypher® Test Surpasses 100,000 Orders, Advancing Precision Risk Assessment for Patients with Barrett's Esophagus - PR Newswire

Castle Biosciences (CSTL) COO sells 8,587 shares, retains over 127K - Stock Titan

How The Castle Biosciences (CSTL) Investment Story Is Evolving Without Fresh Analyst Commentary - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers